Research Article
Intracranial Angioplasty with Enterprise Stent for Intracranial Atherosclerotic Stenosis: A Single-Center Experience and a Systematic Review
Table 1
The patient’s demographic data, clinical and angiographic outcome.
| Characteristic | Value |
| Age, years () | | Sex, male/female () | 60/44 | Qualifying event ( (%)) | | Transient ischemic attack | 21 (20.19) | Cerebral infarction | 83 (79.81) | Comorbidities ( (%)) | | Hypertension | 80 (76.92) | Diabetes | 30 (28.85) | Coronary artery disease | 18 (17.31) | Pretreated modified Rankin scale score ( (%)) | | 0 | 17 (16.35) | 1 | 69 (66.35) | 2 | 16 (15.38) | 3 | 1 (0.96) | Location ( (%)) | | Intracranial segment of internal carotid artery | 13 (12.38) | Middle cerebral artery | 34 (32.38) | Basilar artery | 43 (40.95) | Intracranial segment of the vertebral artery | 15 (14.28) | Lesion morphology ( (%)) | | A | 14 (13.33) | B | 40 (38.10) | C | 51 (48.57) | Complications ( (%)) | | Any stroke or death within 30 d | 7 (6.73) | Nonfatal ischemic stroke within 30 d | 4 (3.85) | Nonfatal hemorrhage stroke within 30 d | 2 (1.92) | Death within 30 d | 1 (0.96) | Angiographic outcome | | Pretreated stenosis degree (%) () | | Posttreated stenosis degree (%) () | | Length of stenosis () | | Enterprise stent length (mm) () | | Balloon catheter length (mm) () | |
|
|